Aphexda™ (motixafortide) – New orphan drug approval
September 11, 2023 - BioLineRx announced the FDA approval of Aphexda (motixafortide), in combination with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with multiple myeloma.
Top